Technology-as-a-service Archives

News Release

Biotricity announces continued margin improvement driven by its proprietary AI cloud

REDWOOD CITY, Calif., Jul 22, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company…

biotricityJuly 22, 2024

News Release

Biotricity announces accelerated path to EBITDA Positive

REDWOOD CITY, Calif., Jul 11, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company…

biotricityJuly 11, 2024

News Release

Biotricity adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program

REDWOOD CITY, Calif., Jul 10, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company…

biotricityJuly 10, 2024

News Release

Biotricity launches Direct-to-Consumer heart health screening service, HeartSecure, making heart health services accessible in response to the #1 global killer, poising company to access the growing home diagnostics market

REDWOOD CITY, Calif., Jun 12, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS)…

biotricityJune 12, 2024

News Release

Biotricity provides year-end guidance with expectations to meet analyst revenue target and beating loss and margin targets

REDWOOD CITY, Calif., Jun 06, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…

biotricityJune 6, 2024

News Release

Biotricity preferred shareholders show increased commitment and support of the company by converting almost all Preferred A shares into Restricted Common Stock

REDWOOD CITY, Calif., Jun 04, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…

biotricityJune 4, 2024

News Release

Biotricity announces the upcoming launch of the first-ever direct-to-patient cardiac screening service, targeting the $1.05B home heart health market

REDWOOD CITY, Calif., May 30, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…

biotricityMay 30, 2024

News Release

Biotricity expands market reach to pulmonary and neurology fields through latest partnerships with two leading home-based diagnostic companies

REDWOOD CITY, Calif., Apr 30, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…

biotricityApril 30, 2024

News Release

Biotricity’s path towards breakeven accelerated by latest diagnostic product, Biotres Pro, garnering rapid interest from existing and new customers

REDWOOD CITY, Calif., Apr 26, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…

biotricityApril 26, 2024

News Release

Biotricity launches major cardiac monitoring pilot program in a hospital system comprised of 9 hospitals and 10 clinics

REDWOOD CITY, Calif., Apr 18, 2024 (ACCESSWIRE) — Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”),…

biotricityApril 18, 2024

Technology-as-a-service

Biotricity announces continued margin improvement driven by its proprietary AI cloud

Biotricity announces accelerated path to EBITDA Positive

Biotricity adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program

Biotricity launches Direct-to-Consumer heart health screening service, HeartSecure, making heart health services accessible in response to the #1 global killer, poising company to access the growing home diagnostics market

Biotricity provides year-end guidance with expectations to meet analyst revenue target and beating loss and margin targets

Biotricity preferred shareholders show increased commitment and support of the company by converting almost all Preferred A shares into Restricted Common Stock

Biotricity announces the upcoming launch of the first-ever direct-to-patient cardiac screening service, targeting the $1.05B home heart health market

Biotricity expands market reach to pulmonary and neurology fields through latest partnerships with two leading home-based diagnostic companies

Biotricity’s path towards breakeven accelerated by latest diagnostic product, Biotres Pro, garnering rapid interest from existing and new customers

Biotricity launches major cardiac monitoring pilot program in a hospital system comprised of 9 hospitals and 10 clinics

Follow Us!

Biotricity Store

Dr. Fareeha Siddiqui

Allia Bukhari

Vice President of Creative

CONTACT US TO LEARN MORE

conact-us

CONTACT US TO LEARN MORE

Al Young

Senior Director of Quality Assurance & (Regulatory Management Representative)

Amjad Talpur

Sr. Director of Operations

Matt Zabel

Vice President of Sales and Strategy

Spencer LaDow

Vice President of Engineering

Amir Ali

Chief Development Officer

Dr. Waqaas Al-Siddiq

Founder & Chief Executive Officer

John Ayanoglou

Chief Financial Officer